Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Shuster

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Blood|October 15, 1993
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemiaG J Kato, F F Quddus, J J Shuster, et al.
Journal of Pediatric Hematology/Oncology|June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot StudyS J Lauer, B M Camitta, B G Leventhal, et al.
Blood|September 26, 2000
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 casesN R Schneider, A J Carroll, J J Shuster, et al.
Blood|June 15, 1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group studyM B Harris, J J Shuster, A Carroll, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Blood|July 1, 1990
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group studyW M Crist, A J Carroll, J J Shuster, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Blood|April 15, 1993
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group studyR O Bash, W M Crist, J J Shuster, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Blood|October 15, 1993
High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemiaG J Kato, F F Quddus, J J Shuster, et al.
Journal of Pediatric Hematology/Oncology|June 17, 1998
Intensive alternating drug pairs after remission induction for treatment of infants with acute lymphoblastic leukemia: A Pediatric Oncology Group Pilot StudyS J Lauer, B M Camitta, B G Leventhal, et al.
Blood|September 26, 2000
New recurring cytogenetic abnormalities and association of blast cell karyotypes with prognosis in childhood T-cell acute lymphoblastic leukemia: a pediatric oncology group report of 343 casesN R Schneider, A J Carroll, J J Shuster, et al.
Blood|June 15, 1992
Trisomy of leukemic cell chromosomes 4 and 10 identifies children with B-progenitor cell acute lymphoblastic leukemia with a very low risk of treatment failure: a Pediatric Oncology Group studyM B Harris, J J Shuster, A Carroll, et al.
Cancer|May 15, 1995
Repetitive low dose oral methotrexate and intravenous mercaptopurine treatment for patients with lower risk B-lineage acute lymphoblastic leukemia. A Pediatric Oncology Group pilot studyD H Mahoney, B M Camitta, B G Leventhal, et al.
Blood|July 1, 1990
Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group studyW M Crist, A J Carroll, J J Shuster, et al.
Blood|February 15, 1997
Case-control study suggests a favorable impact of TEL rearrangement in patients with B-lineage acute lymphoblastic leukemia treated with antimetabolite-based therapy: a Pediatric Oncology Group studyJ E Rubnitz, J J Shuster, V J Land, et al.
Journal of Pediatric Surgery|March 1, 1993
Thoracic neuroblastoma: a Pediatric Oncology Group studyG A Adams, S J Shochat, E I Smith, et al.
Blood|April 15, 1993
Clinical features and outcome of T-cell acute lymphoblastic leukemia in childhood with respect to alterations at the TAL1 locus: a Pediatric Oncology Group studyR O Bash, W M Crist, J J Shuster, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493)L S Frankel, J Ochs, J J Shuster, et al.
Pageof 16